Clinical Trial Update: To Evaluate the Safety and Potential Therapeutic Activity of JadiCell™, an Investigational Umbilical Cord-Derived Mesenchymal Stem Cell Therapy, in Patients Diagnosed With Acute Respiratory Distress Syndrome (ARDS). [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on JadiCell, an investigational umbilical cord-derived mesenchymal stem cell therapy, for acute respiratory distress syndrome; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• JadiCell™

Snippet

Sponsor: Breathe Biologics, Inc. | Conditions: Acute Respiratory Distress Syndrome | Phase 3 | Status: NOT_YET_RECRUITING